Novavax expects $235M-$275M in 2026 adjusted total revenue while targeting $150M-$200M in 2028 non-GAAP R&D and SG&A

Western Midstream outlines 2026 adjusted EBITDA of $2.75B-$2.95B while integrating Brazos acquisition

CarParts.com targets free cash flow positive in 2026 with A-Premium near $50M run rate and 300,000-package last-mile goal

HCI outlines over $10M per quarter reinsurance savings as GEICO begins selling new product

Immunocore outlines TEBE-AM data as early as end of 2026 while scaling KIMMTRAK beyond ~1,000 patients per year